Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment

IntroductionMethimazole (MMI) represents the conventional therapeutic agent for Graves’ disease (GD) hyperthyroidism, but MMI efficacy is limited since it marginally affects the underlying autoimmune process. In a previous study, we randomly assigned 42 newly diagnosed GD patients with insufficient...

Full description

Bibliographic Details
Main Authors: Daniela Gallo, Antonino Bruno, Matteo Gallazzi, Simona Antonia Maria Cattaneo, Giovanni Veronesi, Angelo Genoni, Maria Laura Tanda, Luigi Bartalena, Alberto Passi, Eliana Piantanida, Lorenzo Mortara
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1145811/full